Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.
about
Sensitive, noninvasive detection of lymph node metastasesLymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer.Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literaturePredictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies.Nanoparticles in sentinel lymph node assessment in breast cancer.Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy.Minimal limb volume change has a significant impact on breast cancer survivors.Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancerSentinel Lymph Node Biopsy in Patients with Breast Cancer: Comparison of Peritumoral and Periareolar Injection.Risk factors for lymphedema after breast cancer treatment.Axillary reverse mapping: five-year experience.Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyFactors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.Sentinel lymph node biopsy: technique validation at the Setúbal Medical Centre, PortugalSystematic review of axillary reverse mapping in breast cancer.Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.Decreasing the risk of iatrogenic lymphoedema after axillary surgery: a threefold intervention.Breast cancer recurrence after sentinel lymph node biopsy.Treatment of sentinel node-positive breast cancer.Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 YearsQuality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study.Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms.Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurementsPrevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004Lymphatic mapping and sentinel lymph node biopsy for breast cancer patients.Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.Breast cancer and lymphedema: a current overview for the healthcare provider.Clinical applications of breast pathology: management of in situ breast carcinomas and sentinel node biopsy issues.The use of sentinel node sampling in vulval cancer.Nodal status assessment in breast cancer: strategies of clinical grounds and quality of life implications.Feasibility study of axillary reverse mapping lymphoscintigraphy in carcinoma breast: A concept toward preventing lymphedema.Breast cancer-related lymphoedema and venepuncture: a review and evidence-based recommendations.Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status.Axillary evaluation and lymphedema in women with ductal carcinoma in situ.Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Accessory Joint and Neural Mobilizations for Shoulder Range of Motion Restriction After Breast Cancer Surgery: A Pilot Randomized Clinical Trial.Frequency of Early-Stage Lymphedema and Risk Factors in Postoperative Patients with Breast Cancer
P2860
Q24809609-AD975BBF-D6D5-4F34-935B-77687F5FA900Q24815529-217BF95A-7892-4758-985C-1DEAF1FE87B2Q24815784-95F07948-F010-49CD-8228-0D1D92A73D1BQ30249050-2BC59969-FDAC-4B96-86F3-0C9E7E28B520Q30446788-489C7080-3195-4732-9C10-9E43AAA509EDQ33799441-0046B960-1122-452B-8699-DD3FF6837AE7Q33899017-63AF4F71-B12F-4B47-B2C2-B0BE96B9252CQ33945094-7E850B53-F298-4C3C-B90C-A9D95ED7A333Q34210226-3B206E22-2CDC-442E-AFA6-F022A2F7F3CDQ34293178-383D2C14-126A-4A20-BA8F-DAA13A1BEDD5Q35163199-F9F94436-9F76-4E9A-86A8-C6141FAF1C3CQ35194725-2AE92B0A-25B4-42E3-B9EA-D3FCC79C4714Q35327454-875FDB7A-303F-4403-BCCE-18C31A240880Q35572942-8AAE1DB4-0E7B-4A8D-B3F8-12ACAD36A021Q35867723-DAC5E75E-BA68-4D85-AEE3-BFE496E39443Q35905187-2BF0900B-D504-4DB1-9037-4EDE6AC833B0Q36098586-D9202157-E3EE-4CCE-924C-B25E6014CE75Q36299075-631B53DF-C39B-40E2-88E4-E59421C40918Q36552933-F19F938D-48BF-4B26-9A02-E0D3A43D8EFDQ36573843-10D6C972-85B8-41E7-ADDE-68AED87FE50FQ36744952-AF804FA8-8A52-48E1-81B2-08D8A03A569DQ36841374-A2EAC3AE-B8DB-4551-8748-DB6B50D44E3FQ37104754-76046935-B5C6-420B-9CB7-93C1E5994986Q37119428-7D66ECB8-C009-4162-8DCF-B082C8256531Q37119431-51D6F4EA-A161-47D3-8240-B92C52C4449FQ37276850-7951C665-CA14-46EE-93E9-82884848A4DAQ37478779-E87CDC15-E441-40D9-95C3-D1F321EA29CAQ37602556-4768FF1E-5FD9-4421-B06F-F75A6ED725C0Q37738878-D79B89BE-7AEB-482B-97E0-59907E8230EEQ37740946-0A22CAB0-C9BA-40EF-8719-4EE0C192B3CFQ38161984-B9F7E64B-4916-4BA2-8429-683335B6FA11Q38199690-CFA8095B-64D6-491E-B8DB-2F749283C8D4Q38304694-A861B4A5-8B51-4C8B-855F-581FC1577CA7Q38640801-A2B96006-5036-493A-8912-0307BE3E5E9EQ38905173-83C6D4E4-7C9E-4915-A2CF-85958465336CQ40672624-57547532-A744-4451-8183-0C049EE61843Q40854448-CF18C496-1C89-4715-9088-9E7FD48C8842Q40872781-BC51E348-BBAB-4662-8E1E-17DF28B92F85Q41990939-0F9CF0D6-D975-4B7E-A02A-2BAF9FFEE1E9Q42148875-7495A61D-432B-4931-B7BB-1AD544EFA012
P2860
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Relapse and morbidity in patie ...... dissection for breast cancer.
@en
Relapse and morbidity in patie ...... dissection for breast cancer.
@nl
type
label
Relapse and morbidity in patie ...... dissection for breast cancer.
@en
Relapse and morbidity in patie ...... dissection for breast cancer.
@nl
prefLabel
Relapse and morbidity in patie ...... dissection for breast cancer.
@en
Relapse and morbidity in patie ...... dissection for breast cancer.
@nl
P2093
P1433
P1476
Relapse and morbidity in patie ...... dissection for breast cancer.
@en
P2093
Carol Reynolds
Clive S Grant
D Kay Blanchard
John H Donohue
P304
482-7; discussion 487-8
P356
10.1001/ARCHSURG.138.5.482
P577
2003-05-01T00:00:00Z